Kira Scherer Wampler Sells 2,500 Shares of Doximity, Inc. (NASDAQ:DOCS) Stock

Doximity, Inc. (NASDAQ:DOCSGet Free Report) Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $27.22, for a total transaction of $68,050.00. Following the completion of the transaction, the director now owns 10,258 shares of the company’s stock, valued at $279,222.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Kira Scherer Wampler also recently made the following trade(s):

  • On Monday, April 1st, Kira Scherer Wampler sold 2,500 shares of Doximity stock. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00.

Doximity Stock Performance

NASDAQ:DOCS opened at $28.03 on Friday. Doximity, Inc. has a fifty-two week low of $19.71 and a fifty-two week high of $36.29. The business has a 50 day moving average price of $25.65 and a 200-day moving average price of $26.47. The firm has a market cap of $5.23 billion, a PE ratio of 36.40, a price-to-earnings-growth ratio of 3.53 and a beta of 1.18.

Institutional Investors Weigh In On Doximity

Several institutional investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. increased its position in shares of Doximity by 111.3% in the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after acquiring an additional 524 shares during the period. LRI Investments LLC bought a new stake in shares of Doximity in the first quarter worth about $34,000. GAMMA Investing LLC purchased a new position in Doximity during the 4th quarter valued at about $40,000. Essex Investment Management Co. LLC purchased a new position in Doximity during the 1st quarter valued at about $73,000. Finally, Creative Financial Designs Inc. ADV lifted its holdings in Doximity by 16.7% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock worth $93,000 after buying an additional 473 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analysts Set New Price Targets

DOCS has been the topic of several research analyst reports. Leerink Partnrs reaffirmed a “market perform” rating on shares of Doximity in a report on Monday, February 26th. JPMorgan Chase & Co. upgraded Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 target price for the company in a research report on Thursday, April 25th. William Blair reaffirmed an “outperform” rating on shares of Doximity in a report on Friday. Truist Financial increased their price target on shares of Doximity from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Friday, February 9th. Finally, Bank of America boosted their target price on Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 23rd. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $28.73.

Read Our Latest Stock Report on DOCS

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Insider Buying and Selling by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.